Identification of novel host-targeted compounds that protect from anthrax lethal toxin-induced cell death

ACS Chemical Biology

Volumn 8, Issue 4, 2013, Pages 812-822

  Slater, Louise H ^a,b,c   Hett, Erik C ^a,b,c   Mark, Kevin ^a,b,c   Chumbler, Nicole M ^d   Patel, Deepa ^c   Lacy, D Borden ^d   Collier, R John ^c   Hung, Deborah T ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIFICATION; ARTICLE; BACILLUS ANTHRACIS; CELL DEATH; CELL FUNCTION; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; ENDOCYTOSIS; MACROPHAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CELL DEATH; CELL LINE; DRUGS, CHINESE HERBAL; ENDOCYTOSIS; HIGH-THROUGHPUT SCREENING ASSAYS; MACROPHAGES; MICE;

BACILLUS ANTHRACIS; CLOSTRIDIUM DIFFICILE;

EID: 84876549670     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300555n     Document Type: Article

References (77)

1. Collier, R. J. (2009) Membrane translocation by anthrax toxin Mol. Aspects Med. 30, 413-422
2. Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D., Ahn, N. G., Oskarsson, M. K., Fukasawa, K., Paull, K. D., and Vande Woude, G. F. (1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor Science 280, 734-737
3. Vitale, G., Bernardi, L., Napolitani, G., Mock, M., and Montecucco, C. (2000) Susceptibility of mitogen-Activated protein kinase kinase family members to proteolysis by anthrax lethal factor Biochem. J. 352 (Pt 3) 739-745
4. Vitale, G., Pellizzari, R., Recchi, C., Napolitani, G., Mock, M., and Montecucco, C. (1998) Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages Biochem. Biophys. Res. Commun. 248, 706-711
5. Levinsohn, J. L., Newman, Z. L., Hellmich, K. A., Fattah, R., Getz, M. A., Liu, S., Sastalla, I., Leppla, S. H., and Moayeri, M. (2012) Anthrax lethal factor cleavage of nlrp1 is required for activation of the inflammasome PLoS Pathog. 8, e1002638
6. Leppla, S. H. (1982) Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells Proc. Natl. Acad. Sci. U.S.A. 79, 3162-3166
7. Boyden, E. D. and Dietrich, W. F. (2006) Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin Nat. Genet. 38, 240-244
8. Fink, S. L., Bergsbaken, T., and Cookson, B. T. (2008) Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms Proc. Natl. Acad. Sci. U.S.A. 105, 4312-4317
9. Muehlbauer, S. M., Evering, T. H., Bonuccelli, G., Squires, R. C., Ashton, A. W., Porcelli, S. A., Lisanti, M. P., and Brojatsch, J. (2007) Anthrax lethal toxin kills macrophages in a strain-specific manner by apoptosis or caspase-1-mediated necrosis Cell Cycle 6, 758-766
10. Welkos, S. L., Keener, T. J., and Gibbs, P. H. (1986) Differences in susceptibility of inbred mice to Bacillus anthracis Infect. Immun. 51, 795-800
11. Stanley, J. L. and Smith, H. (1961) Purification of factor I and recognition of a third factor of the anthrax toxin J. Gen. Microbiol. 26, 49-63
12. Levy, H., Weiss, S., Altboum, Z., Schlomovitz, J., Rothschild, N., Glinert, I., Sittner, A., and Kobiler, D. (2012) The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits Microb. Pathog. 52, 55-60
13. Lovchik, J. A., Drysdale, M., Koehler, T. M., Hutt, J. A., and Lyons, C. R. (2012) Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax Infect. Immun. 80, 2414-2425
14. van der Goot, G. and Young, J. A. (2009) Receptors of anthrax toxin and cell entry Mol. Aspects Med. 30, 406-412
15. Feld, G. K., Thoren, K. L., Kintzer, A. F., Sterling, H. J., Taang, I. I., Greenberg, S. G., Williams, E. R., and Krantz, B. A. (2010) Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers Nat. Struct. Mol. Biol. 17, 1383-1390
16. Mogridge, J., Cunningham, K., and Collier, R. J. (2002) Stoichiometry of anthrax toxin complexes Biochemistry 41, 1079-1082
17. Abrami, L., Lindsay, M., Parton, R. G., Leppla, S. H., and van der Goot, F. G. (2004) Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway J. Cell Biol. 166, 645-651
18. Friedlander, A. M. (1986) Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process J. Biol. Chem. 261, 7123-7126
19. Milne, J. C., Furlong, D., Hanna, P. C., Wall, J. S., and Collier, R. J. (1994) Anthrax protective antigen forms oligomers during intoxication of mammalian cells J. Biol. Chem. 269, 20607-20612
20. Milne, J. C. and Collier, R. J. (1993) pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen Mol. Microbiol. 10, 647-653
21. Sanchez, A. M., Thomas, D., Gillespie, E. J., Damoiseaux, R., Rogers, J., Saxe, J. P., Huang, J., Manchester, M., and Bradley, K. A. (2007) Amiodarone and bepridil inhibit anthrax toxin entry into host cells Antimicrob. Agents Chemother. 51, 2403-2411
22. Zhu, P. J., Hobson, J. P., Southall, N., Qiu, C., Thomas, C. J., Lu, J., Inglese, J., Zheng, W., Leppla, S. H., Bugge, T. H., Austin, C. P., and Liu, S. (2009) Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death Bioorg. Med. Chem. 17, 5139-5145
23. Panchal, R. G., Ruthel, G., Brittingham, K. C., Lane, D., Kenny, T. A., Gussio, R., Lazo, J. S., and Bavari, S. (2007) Chemical genetic screening identifies critical pathways in anthrax lethal toxin-induced pathogenesis Chem. Biol. 14, 245-255
24. Fischer, A., Nakai, Y., Eubanks, L. M., Clancy, C. M., Tepp, W. H., Pellett, S., Dickerson, T. J., Johnson, E. A., Janda, K. D., and Montal, M. (2009) Bimodal modulation of the botulinum neurotoxin protein-conducting channel Proc. Natl. Acad. Sci. U.S.A. 106, 1330-1335
25. Burke, M. D., Berger, E. M., and Schreiber, S. L. (2004) A synthesis strategy yielding skeletally diverse small molecules combinatorially J. Am. Chem. Soc. 126, 14095-14104
26. Drose, S., Bindseil, K. U., Bowman, E. J., Siebers, A., Zeeck, A., and Altendorf, K. (1993) Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases Biochemistry 32, 3902-3906
27. Mayle, K. M., Le, A. M., and Kamei, D. T. (2011) The intracellular trafficking pathway of transferrin Biochim. Biophys. Acta 1820, 264-281
28. Geisow, M. J. and Evans, W. H. (1984) pH in the endosome. Measurements during pinocytosis and receptor-mediated endocytosis Exp. Cell Res. 150, 36-46
29. Murphy, R. F. (1985) Analysis and isolation of endocytic vesicles by flow cytometry and sorting: demonstration of three kinetically distinct compartments involved in fluid-phase endocytosis Proc. Natl. Acad. Sci. U.S.A. 82, 8523-8526
30. Abrami, L., Liu, S., Cosson, P., Leppla, S. H., and van der Goot, F. G. (2003) Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process J. Cell Biol. 160, 321-328
31. Abrami, L., Bischofberger, M., Kunz, B., Groux, R., and van der Goot, F. G. (2010) Endocytosis of the anthrax toxin is mediated by clathrin, actin and unconventional adaptors PLoS Pathog. 6, e1000792
32. Abrami, L., Leppla, S. H., and van der Goot, F. G. (2006) Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis J. Cell Biol. 172, 309-320
33. Abrami, L., Kunz, B., and van der Goot, F. G. (2010) Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake Proc. Natl. Acad. Sci. U.S.A. 107, 1420-1424
34. Wang Wen-Lu, W. Y. and Chiu Shin-F, N. (1994) The toxic chemical factors in the fruits of Melia azedarach and their bio-Activities towards Pieris rapae Acta Entomol. Sin. 37, 20-24
35. Shih, Y. L. and Hsu, K. (1983) Anti-botulismic effect of toosendanin and its facilitatory action on miniature end-plate potentials Jpn. J. Physiol. 33, 677-680
36. Zou, J., Miao, W. Y., Ding, F. H., Meng, J. Y., Ye, H. J., Jia, G. R., He, X. Y., Sun, G. Z., and Li, P. Z. (1985) The effect of toosendanin on monkey botulism J. Tradit. Chin. Med. 5, 29-30
37. Zhou, J. Y., Wang, Z. F., Ren, X. M., Tang, M. Z., and Shi, Y. L. (2003) Antagonism of botulinum toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin FEBS Lett. 555, 375-379
38. Li, M. F. and Shi, Y. L. (2006) Toosendanin interferes with pore formation of botulinum toxin type A in PC12 cell membrane Acta Pharmacol. Sin. 27, 66-70
39. Sun, S., Suresh, S., Liu, H., Tepp, W. H., Johnson, E. A., Edwardson, J. M., and Chapman, E. R. (2011) Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly Cell Host Microbe 10, 237-247
40. Shi, Y. L. and Li, M. F. (2007) Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicine Prog. Neurobiol. 82, 1-10
41. Wang, Z. F. and Shi, Y. L. (2001) Modulation of inward rectifier potassium channel by toosendanin, a presynaptic blocker Neurosci. Res. 40, 211-215
42. Wang, Z. F. and Shi, Y. L. (2001) Inhibition of large-conductance Ca(2+)-Activated K(+) channels in hippocampal neurons by toosendanin Neuroscience 104, 41-47
43. Wang, Z. F. and Shi, Y. L. (2001) Toosendanin-induced inhibition of small-conductance calcium-Activated potassium channels in CA1 pyramidal neurons of rat hippocampus Neurosci. Lett. 303, 13-16
44. Li, M. F. and Shi, Y. L. (2004) Toosendanin, a triterpenoid derivative, acts as a novel agonist of L-type Ca2+ channels in neonatal rat ventricular cells Eur. J. Pharmacol. 501, 71-78
45. Li, M. F., Wu, Y., Wang, Z. F., and Shi, Y. L. (2004) Toosendanin, a triterpenoid derivative, increases Ca2+ current in NG108-15 cells via L-type channels Neurosci. Res. 49, 197-203
46. Watanabe, T., Sakamoto, N., Nakagawa, M., Kakinuma, S., Itsui, Y., Nishimura-Sakurai, Y., Ueyama, M., Funaoka, Y., Kitazume, A., Nitta, S., Kiyohashi, K., Murakawa, M., Azuma, S., Tsuchiya, K., Oooka, S., and Watanabe, M. (2011) Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection Antimicrob. Agents Chemother. 55, 2537-2545
47. Voth, D. E. and Ballard, J. D. (2005) Clostridium difficile toxins: mechanism of action and role in disease Clin. Microbiol. Rev. 18, 247-263
48. Papatheodorou, P., Zamboglou, C., Genisyuerek, S., Guttenberg, G., and Aktories, K. (2010) Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis PLoS One 5, e10673
49. Squires, R. C., Muehlbauer, S. M., and Brojatsch, J. (2007) Proteasomes control caspase-1 activation in anthrax lethal toxin-mediated cell killing J. Biol. Chem. 282, 34260-34267
50. Zheng, C. H., Zhou, Y. J., Zhu, J., Ji, H. T., Chen, J., Li, Y. W., Sheng, C. Q., Lu, J. G., Jiang, J. H., Tang, H., and Song, Y. L. (2007) Construction of a three-dimensional pharmacophore for Bcl-2 inhibitors by flexible docking and the multiple copy simultaneous search method Bioorg. Med. Chem. 15, 6407-6417
51. Enyedy, I. J., Ling, Y., Nacro, K., Tomita, Y., Wu, X., Cao, Y., Guo, R., Li, B., Zhu, X., Huang, Y., Long, Y. Q., Roller, P. P., Yang, D., and Wang, S. (2001) Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening J. Med. Chem. 44, 4313-4324
52. Huang, D. C., Adams, J. M., and Cory, S. (1998) The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4 EMBO J. 17, 1029-1039
53. Pan, G., O'Rourke, K., and Dixit, V. M. (1998) Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex J. Biol. Chem. 273, 5841-5845
54. Vogler, M., Dinsdale, D., Dyer, M. J., and Cohen, G. M. (2009) Bcl-2 inhibitors: small molecules with a big impact on cancer therapy Cell Death Differ. 16, 360-367
55. Meng, L., Mohan, R., Kwok, B. H., Elofsson, M., Sin, N., and Crews, C. M. (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity Proc. Natl. Acad. Sci. U.S.A. 96, 10403-10408
56. Milne, J. C., Blanke, S. R., Hanna, P. C., and Collier, R. J. (1995) Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus Mol. Microbiol. 15, 661-666
57. Bernard, A. and Payton, M. (2001) Fermentation and growth of Escherichia coli for optimal protein production Curr. Protoc. Protein Sci. 10.1002/0471140864.ps0503s00
58. Miller, C. J., Elliott, J. L., and Collier, R. J. (1999) Anthrax protective antigen: prepore-to-pore conversion Biochemistry 38, 10432-10441
59. Zhang, S., Finkelstein, A., and Collier, R. J. (2004) Evidence that translocation of anthrax toxin's lethal factor is initiated by entry of its N terminus into the protective antigen channel Proc. Natl. Acad. Sci. U.S.A. 101, 16756-16761
60. Qa'Dan, M., Spyres, L. M., and Ballard, J. D. (2000) pH-induced conformational changes in Clostridium difficile toxin B Infect. Immun. 68, 2470-2474
61. Muroi, M., Shiragami, N., and Takatsuki, A. (1994) Destruxin B, a specific and readily reversible inhibitor of vacuolar-type H(+)-translocating ATPase Biochem. Biophys. Res. Commun. 205, 1358-1365
62. Lyss, G., Knorre, A., Schmidt, T. J., Pahl, H. L., and Merfort, I. (1998) The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65 J. Biol. Chem. 273, 33508-33516
63. Kawakami, Y., Hartman, S. E., Kinoshita, E., Suzuki, H., Kitaura, J., Yao, L., Inagaki, N., Franco, A., Hata, D., Maeda-Yamamoto, M., Fukamachi, H., Nagai, H., and Kawakami, T. (1999) Terreic acid, a quinone epoxide inhibitor of Bruton's tyrosine kinase Proc. Natl. Acad. Sci. U.S.A. 96, 2227-2232
64. Iwamaru, A., Szymanski, S., Iwado, E., Aoki, H., Yokoyama, T., Fokt, I., Hess, K., Conrad, C., Madden, T., Sawaya, R., Kondo, S., Priebe, W., and Kondo, Y. (2007) A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo Oncogene 26, 2435-2444
65. Mylecharane, E. J. (1991) 5-HT2 receptor antagonists and migraine therapy J. Neurol. 238 (Suppl 1) S45-52
66. Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., and Loriolle, F. 1991, The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C J. Biol. Chem. 266, 15771-15781
67. Duan, Z., Bradner, J. E., Greenberg, E., Levine, R., Foster, R., Mahoney, J., and Seiden, M. V. (2006) SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation Clin. Cancer Res. 12, 6844-6852
68. Hiyama, Y. and Kuriyama, K. (1991) Dissociation between antiinflammatory action of tilorone and its interferon inducing activity Agents Actions 33, 229-232
69. Alonso-Gomez, A. L. and Iuvone, P. M. (1995) Melatonin biosynthesis in cultured chick retinal photoreceptor cells: calcium and cyclic AMP protect serotonin N-Acetyltransferase from inactivation in cycloheximide-treated cells J. Neurochem. 65, 1054-1060
70. Blaskovich, M. A., Sun, J., Cantor, A., Turkson, J., Jove, R., and Sebti, S. M. (2003) Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice Cancer Res. 63, 1270-1279
71. Schust, J., Sperl, B., Hollis, A., Mayer, T. U., and Berg, T. (2006) Stattic: a small-molecule inhibitor of STAT3 activation and dimerization Chem Biol 13, 1235-1242
72. Lipsky, J. J., Shen, M. L., and Naylor, S. (2001) In vivo inhibition of aldehyde dehydrogenase by disulfiram Chem. Biol. Interact. 130-132, 93-102
73. Sharma, S. V., Agatsuma, T., and Nakano, H. (1998) Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol Oncogene 16, 2639-2645
74. Kwon, H. J., Yoshida, M., Fukui, Y., Horinouchi, S., and Beppu, T. (1992) Potent and specific inhibition of p60v-src protein kinase both in vivo and in vitro by radicicol Cancer Res. 52, 6926-6930
75. Kreuter, M. H., Leake, R. E., Rinaldi, F., Muller-Klieser, W., Maidhof, A., Muller, W. E., and Schroder, H. C. (1990) Inhibition of intrinsic protein tyrosine kinase activity of EGF-receptor kinase complex from human breast cancer cells by the marine sponge metabolite (+)-Aeroplysinin-1 Comp. Biochem. Physiol. B 97, 151-158
76. Li, Y. M., Mackintosh, C., and Casida, J. E. (1993) Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues Biochem. Pharmacol. 46, 1435-1443
77. Marmy-Conus, N., Hannan, K. M., and Pearson, R. B. (2002) Ro 31-6045, the inactive analogue of the protein kinase C inhibitor Ro 31-8220, blocks in vivo activation of p70(s6k)/p85(s6k): implications for the analysis of S6K signalling FEBS Lett. 519, 135-140